Fairscale Capital »

Crispr Therapeutics shares owned by Fairscale Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.5k 117 46.98
2024-06-30 $13k 208 62.75